SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-049182
Filing Date
2024-04-26
Accepted
2024-04-26 16:21:47
Documents
20
Period of Report
2024-05-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A acad-20240426.htm   iXBRL DEF 14A 2806924
2 GRAPHIC img237201744_0.jpg GRAPHIC 11677
3 GRAPHIC img237201744_1.jpg GRAPHIC 11677
4 GRAPHIC img237201744_2.jpg GRAPHIC 2081
5 GRAPHIC img237201744_3.jpg GRAPHIC 1149318
6 GRAPHIC img237201744_4.jpg GRAPHIC 248894
7 GRAPHIC img237201744_5.jpg GRAPHIC 208541
8 GRAPHIC img237201744_6.jpg GRAPHIC 199904
9 GRAPHIC img237201744_7.jpg GRAPHIC 250086
10 GRAPHIC img237201744_8.jpg GRAPHIC 353307
  Complete submission text file 0000950170-24-049182.txt   9581834

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acad-20240426.xsd EX-101.SCH 29089
23 EXTRACTED XBRL INSTANCE DOCUMENT acad-20240426_htm.xml XML 301090
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50768 | Film No.: 24884141
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)